6.04 -0.49 (-7.5%) | 02-14 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 7.79 ![]() |
1-year : | 9.57 ![]() |
Resists | First : | 6.67 ![]() |
Second : | 8.19 ![]() |
Pivot price | 6.66 ![]() |
|||
Supports | First : | 4.19 ![]() |
Second : | 3.49 ![]() |
MAs | MA(5) : | 7.02 ![]() |
MA(20) : | 6.15 ![]() |
MA(100) : | 2.95 ![]() |
MA(250) : | 1.56 ![]() |
|
MACD | MACD : | 0.6 ![]() |
Signal : | 0.6 ![]() |
%K %D | K(14,3) : | 60.4 ![]() |
D(3) : | 73.8 ![]() |
RSI | RSI(14): 50 ![]() |
|||
52-week | High : | 8.19 | Low : | 0.18 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ MYNZ ] has closed above bottom band by 32.3%. Bollinger Bands are 36.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 6.61 - 6.66 | 6.66 - 6.7 |
Low: | 5.87 - 5.92 | 5.92 - 5.96 |
Close: | 5.97 - 6.05 | 6.05 - 6.11 |
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Mon, 27 Jan 2025
Mainz Biomed Regains Nasdaq Listing Compliance - TipRanks
Tue, 14 Jan 2025
Mainz Biomed B.V. Addresses Nasdaq Listing Compliance Issue - TipRanks
Thu, 19 Dec 2024
Mainz Biomed stock higher on Quest deal (MYNZ:NASDAQ) - Seeking Alpha
Wed, 18 Dec 2024
Mainz Biomed stock hits 52-week low at $4.3 amid sharp annual decline - Investing.com
Tue, 10 Dec 2024
Mainz Biomed stock hits 52-week low at $6.12 amid market challenges - Investing.com
Mon, 02 Dec 2024
Mainz Biomed announces 1-for-40 reverse stock split - Medical Buyer
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Diagnostics & Research
|
|
Shares Out | -13 (M) |
Shares Float | 0 (M) |
Held by Insiders | 2.22e+006 (%) |
Held by Institutions | 2.209e+007 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 540960 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | -44.41 |
Profit Margin | 0 % |
Operating Margin | -1 % |
Return on Assets (ttm) | 883.2 % |
Return on Equity (ttm) | -99.3 % |
Qtrly Rev. Growth | 333.7 % |
Gross Profit (p.s.) | 123.33 |
Sales Per Share | -3368.89 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | -2.159e+007 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | -0.14 |
Price to Sales | -0.01 |
Price to Cash Flow | 0 |
Dividend | 41310 |
Forward Dividend | 123200 |
Dividend Yield | 683940% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |